BR112014019136A8 - (1r,4r)-6'-fluoro-(n-metil ou-n,n-dimetil-)-4-fenil-4',9'-dihidro-3'h-espiro-[ciclohexano-1,1'-pirano[3,4,b]indol]-4-amina para o tratamento de fibromialgia e síndrome da fadiga crônica - Google Patents
(1r,4r)-6'-fluoro-(n-metil ou-n,n-dimetil-)-4-fenil-4',9'-dihidro-3'h-espiro-[ciclohexano-1,1'-pirano[3,4,b]indol]-4-amina para o tratamento de fibromialgia e síndrome da fadiga crônicaInfo
- Publication number
- BR112014019136A8 BR112014019136A8 BR112014019136A BR112014019136A BR112014019136A8 BR 112014019136 A8 BR112014019136 A8 BR 112014019136A8 BR 112014019136 A BR112014019136 A BR 112014019136A BR 112014019136 A BR112014019136 A BR 112014019136A BR 112014019136 A8 BR112014019136 A8 BR 112014019136A8
- Authority
- BR
- Brazil
- Prior art keywords
- fibromyalgia
- indol
- spiro
- dihydro
- fluoro
- Prior art date
Links
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 title abstract 3
- 208000001640 Fibromyalgia Diseases 0.000 title abstract 3
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 title abstract 3
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title abstract 2
- 239000002552 dosage form Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12000743 | 2012-02-03 | ||
| PCT/EP2013/051979 WO2013113857A1 (en) | 2012-02-03 | 2013-02-01 | (1r,4r)-6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro-[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for treating fibromyalgia and chronic fatigue syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112014019136A2 BR112014019136A2 (https=) | 2017-06-20 |
| BR112014019136A8 true BR112014019136A8 (pt) | 2017-07-11 |
Family
ID=47628188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014019136A BR112014019136A8 (pt) | 2012-02-03 | 2013-02-01 | (1r,4r)-6'-fluoro-(n-metil ou-n,n-dimetil-)-4-fenil-4',9'-dihidro-3'h-espiro-[ciclohexano-1,1'-pirano[3,4,b]indol]-4-amina para o tratamento de fibromialgia e síndrome da fadiga crônica |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20130202701A1 (https=) |
| EP (1) | EP2809320B1 (https=) |
| JP (1) | JP6126134B2 (https=) |
| KR (1) | KR102061482B1 (https=) |
| CN (1) | CN104168897B (https=) |
| AU (1) | AU2013214223B2 (https=) |
| BR (1) | BR112014019136A8 (https=) |
| CA (1) | CA2863572C (https=) |
| CY (1) | CY1118799T1 (https=) |
| DK (1) | DK2809320T3 (https=) |
| EA (1) | EA025500B1 (https=) |
| ES (1) | ES2629211T3 (https=) |
| HR (1) | HRP20170581T1 (https=) |
| IL (1) | IL233871B (https=) |
| LT (1) | LT2809320T (https=) |
| MX (1) | MX353740B (https=) |
| NZ (1) | NZ629800A (https=) |
| PL (1) | PL2809320T3 (https=) |
| PT (1) | PT2809320T (https=) |
| RS (1) | RS56097B1 (https=) |
| SI (1) | SI2809320T1 (https=) |
| WO (1) | WO2013113857A1 (https=) |
| ZA (1) | ZA201406447B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6673924B2 (ja) | 2015-01-23 | 2020-03-25 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 肝機能障害および／または腎機能障害を有する対象における疼痛を治療するためのセブラノパドール |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5900420A (en) * | 1997-06-19 | 1999-05-04 | Cole; William L. | Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine |
| DE10252667A1 (de) * | 2002-11-11 | 2004-05-27 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| DE10360792A1 (de) * | 2003-12-23 | 2005-07-28 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| US7354925B2 (en) * | 2004-03-29 | 2008-04-08 | Pfizer Inc. | Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as ORL1-receptor antagonists |
| AU2007254751A1 (en) * | 2006-05-31 | 2007-12-13 | Sepracor Inc. | Treatment of pain disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine and its formamide |
| DE102006046745A1 (de) * | 2006-09-29 | 2008-04-03 | Grünenthal GmbH | Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz |
-
2013
- 2013-02-01 EA EA201400857A patent/EA025500B1/ru not_active IP Right Cessation
- 2013-02-01 CA CA2863572A patent/CA2863572C/en not_active Expired - Fee Related
- 2013-02-01 SI SI201330672A patent/SI2809320T1/sl unknown
- 2013-02-01 WO PCT/EP2013/051979 patent/WO2013113857A1/en not_active Ceased
- 2013-02-01 PL PL13701807T patent/PL2809320T3/pl unknown
- 2013-02-01 DK DK13701807.3T patent/DK2809320T3/en active
- 2013-02-01 RS RS20170602A patent/RS56097B1/sr unknown
- 2013-02-01 LT LTEP13701807.3T patent/LT2809320T/lt unknown
- 2013-02-01 EP EP13701807.3A patent/EP2809320B1/en active Active
- 2013-02-01 NZ NZ629800A patent/NZ629800A/en not_active IP Right Cessation
- 2013-02-01 US US13/757,223 patent/US20130202701A1/en not_active Abandoned
- 2013-02-01 HR HRP20170581TT patent/HRP20170581T1/hr unknown
- 2013-02-01 ES ES13701807.3T patent/ES2629211T3/es active Active
- 2013-02-01 CN CN201380007809.0A patent/CN104168897B/zh not_active Expired - Fee Related
- 2013-02-01 KR KR1020147024696A patent/KR102061482B1/ko not_active Expired - Fee Related
- 2013-02-01 AU AU2013214223A patent/AU2013214223B2/en not_active Ceased
- 2013-02-01 BR BR112014019136A patent/BR112014019136A8/pt not_active Application Discontinuation
- 2013-02-01 JP JP2014555212A patent/JP6126134B2/ja active Active
- 2013-02-01 PT PT137018073T patent/PT2809320T/pt unknown
- 2013-02-01 MX MX2014008865A patent/MX353740B/es active IP Right Grant
-
2014
- 2014-07-30 IL IL233871A patent/IL233871B/en active IP Right Grant
- 2014-09-02 ZA ZA2014/06447A patent/ZA201406447B/en unknown
-
2017
- 2017-04-03 CY CY20171100395T patent/CY1118799T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013214223B2 (en) | 2017-03-23 |
| SI2809320T1 (sl) | 2017-07-31 |
| IL233871B (en) | 2018-06-28 |
| CN104168897B (zh) | 2016-09-28 |
| EP2809320A1 (en) | 2014-12-10 |
| KR20140130695A (ko) | 2014-11-11 |
| JP2015505553A (ja) | 2015-02-23 |
| US20130202701A1 (en) | 2013-08-08 |
| MX2014008865A (es) | 2014-08-27 |
| JP6126134B2 (ja) | 2017-05-10 |
| EA025500B1 (ru) | 2016-12-30 |
| LT2809320T (lt) | 2017-05-25 |
| WO2013113857A1 (en) | 2013-08-08 |
| EA201400857A1 (ru) | 2015-01-30 |
| CN104168897A (zh) | 2014-11-26 |
| PL2809320T3 (pl) | 2017-09-29 |
| RS56097B1 (sr) | 2017-10-31 |
| IL233871A0 (en) | 2014-09-30 |
| KR102061482B1 (ko) | 2020-01-03 |
| CA2863572C (en) | 2019-08-27 |
| HK1199218A1 (en) | 2015-06-26 |
| BR112014019136A2 (https=) | 2017-06-20 |
| CA2863572A1 (en) | 2013-08-08 |
| ZA201406447B (en) | 2016-02-24 |
| DK2809320T3 (en) | 2017-05-15 |
| MX353740B (es) | 2018-01-26 |
| CY1118799T1 (el) | 2018-01-10 |
| PT2809320T (pt) | 2017-06-30 |
| AU2013214223A1 (en) | 2014-09-18 |
| HRP20170581T1 (hr) | 2017-06-16 |
| ES2629211T3 (es) | 2017-08-07 |
| NZ629800A (en) | 2016-06-24 |
| EP2809320B1 (en) | 2017-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2012016697A3 (en) | Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain | |
| BR112015020389A8 (pt) | compostos carbazol úteis como inibidores de bromodomínio, seu uso, bem como composição e produto farmacêuticos compreendendo os mesmos | |
| DOP2013000192A (es) | Compuestos y composiciones como inhibidores de la trk | |
| WO2014205389A8 (en) | Nuclear transport modulators and uses thereof | |
| UY35907A (es) | Nuevas indazolcarboxamidas, procedimientos para su preparación, preparaciones farmaceuticas que las contienen, así como su uso para la preparación de medicamentos | |
| BR112015027282A2 (pt) | fenfluramina para uso no tratamento de síndrome de dravet | |
| WO2013170068A3 (en) | Nuclear transport modulators and uses thereof | |
| BRPI1011220A2 (pt) | composição farmacêutica, métodos para tratar uma doença ou distúrbio, para administração respiratória de dois ou mais agentes ativos, para administração respiratória de uma combinação de agentes ativos, e, para preparar uma composição adequada. | |
| WO2015054619A8 (en) | Use of a pcsk9 inhibitor to treat hyperlipidemia | |
| BR112013004055A2 (pt) | Forma de dosagem farmacêutica compreendendo 6'-fluor-(n-metil- ou n, n-dimetil-)-4-fenil-4',9'-di- hidro-3'h-espiro[cicloexano-1,1'-pirano[3,4-b]indol]-4 -amina. | |
| EA201590655A8 (ru) | Комбинация лахинимода и придопидина для лечения нейродегенеративных нарушений | |
| EA201590654A1 (ru) | Комбинация разагилина и придопидина для лечения нейродегенеративных нарушений, в частности болезни хантингтона | |
| PY1330684A (es) | Tratamiento de la esclerosis múltiple con una combinación de laquinimod y fampridina | |
| BR102012028120B8 (pt) | Uso de um ou mais derivados de ingenol, composição farmacêutica e medicamento | |
| PT2849745T (pt) | Composição farmacêutica compreendendo (1r,4r)-6'-fluoro-n,n-dimetil-4-fenil-4',9'-di-hidro-3'h-espiro[ciclo-hexano-1,1'-pirano[3,4,b]indol]-4-amina e ibuprofeno | |
| BR112013002714A2 (pt) | forma de dosagem farmacêutica compreendendo 6-fluor-(n-metil- ou n,n-dimetil)-4-fenil-4,9-di-hidro-3h-espiro[ciclo-hexano-1,1-pirano[3,4,b]indol]-4-amina | |
| BR112013024791A2 (pt) | aclidínio para uso na melhoria da qualidade do sono em pacientes com sintomas respiratórios, composição farmacêutica compreendendo o mesmo e seus usos. | |
| CY1119777T1 (el) | Φαρμακευτικη συνθεση περιλαμβανουσα (1r,4r)-6'-φθοpo-n,n-διμεθυλ-4-φαινυλ-4',9'διυδρο-3'h-σπειρο[κυκλοεξανο-1,1'-πυρανο[3,4,β]ινδολ]-4-αμινη και γκαμπαπεντινοειδες | |
| BR112014030288A8 (pt) | composição farmacêutica, uso da mesma, e, uso de metanossulfonilacetonitrila | |
| BR112014019136A8 (pt) | (1r,4r)-6'-fluoro-(n-metil ou-n,n-dimetil-)-4-fenil-4',9'-dihidro-3'h-espiro-[ciclohexano-1,1'-pirano[3,4,b]indol]-4-amina para o tratamento de fibromialgia e síndrome da fadiga crônica | |
| HRP20171843T1 (hr) | Farmaceutski pripravak koji sadrži (1r,4r)-6'-fluoro-n,n-dimetil-4-fenil-4',9'-dihidro-3'h-spiro[cikloheksan-1,1'-pirano [3,4,b]indol]-4-amin i meloksikam | |
| EA201401272A1 (ru) | Фармацевтическая композиция, содержащая (1r,4r)-6'-фтор-n,n-диметил-4-фенил-4',9'-дигидро-3'h-спиро[циклогексан-1,1'-пирано-[3,4,b]индол]-4-амин и парацетамол или пропацетамол | |
| EA201500366A1 (ru) | Применение 1-адамантилетилокси-3-морфолино-2-пропанола или его фармацевтически приемлемых солей в фармацевтических композициях в качестве нейроретинопротектора | |
| BR112014010719A2 (pt) | moduladores não competitivos de receptor nicotínico | |
| CY1120970T1 (el) | Φαρμακευτικη μορφη δοσολογιας που περιλαμβανει 6'-φθορο-(ν-μεθυλ-ή ν,ν-διμεθυλ-)-4-φαινυλ-4',9'-διυδρο-3ή-σπeipo[kykλoeξano-1,1'-πυρano[3,4,b]inδoλ]-4-aminh για την αγωγη του αλγαισθητικου πονου |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |